TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ERTYGENCE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ERTYGENCE

ST13

US500000079325366

Class

5

Filing

79325366

Registration

6749527

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

10/10/2022

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

09/20/2021

Registration date

06/07/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/07/2022

Last transaction

06/07/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

27

Owner location

DE

Examiner

XU, ELAINE YILIN

Law office

N90

Current location

TMO LAW OFFICE 127

Holders and representatives

Holders

Boehringer Ingelheim International GmbH

Representatives

Max Moskowitz Ostrolenk Faber LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; cell based immune therapeutic pharmaceuticals for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases

Publications

History of USPTO decisions and trademark events.

26 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/10/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/21/2022

FIMP

FINAL DISPOSITION PROCESSED

09/21/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/07/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/07/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

06/07/2022

GPNX

NOTIFICATION PROCESSED BY IB

03/22/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/22/2022

PUBO

PUBLISHED FOR OPPOSITION

03/22/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/02/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/02/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/02/2022

RFNT

REFUSAL PROCESSED BY IB

02/20/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/16/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/16/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/15/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/15/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/28/2022

RFRR

REFUSAL PROCESSED BY MPU

01/28/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/06/2022

CNRT

NON-FINAL ACTION WRITTEN

01/05/2022

DOCK

ASSIGNED TO EXAMINER

01/04/2022

MAFR

APPLICATION FILING RECEIPT MAILED

11/26/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/22/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

11/22/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/11/2021

Continuous trademark protection

Get notified about every new filing that threatens ERTYGENCE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.